Healthcare >> CEO Interviews >> May 29, 2000
MARTIN NASH has been the Chief Executive Officer of Genetronics
Biomedical Ltd. since September 1999 and its Chief Financial Officer
since June 1999. He was Senior Vice President of Genetronics from 1994 '
1999 and has been a member of the Board of Directors since April 1996.
Prior to joining Genetronics in 1994, Mr. Nash was co-Founder, Chief
Executive Officer and Chief Financial Officer of Cypros Pharmaceutical
Corporation, co-founder of Corvas International, Inc., and Vice
President of Corporate Development at Synbiotics. He was also President
of Molecular Biosystems, Inc. and held a variety of marketing and
business development management positions at Ortho Diagnostics, Inc., a
division of Johnson & Johnson, and at Becton Dickinson & Company. In
1990, Mr. Nash was President of the Association of Biotechnology
Companies. Mr. Nash earned a BA degree from Boston College. Profile
TWST: Give us an overview of Genetronics Biomedical, including thecompany's history, activities and developments.
Mr. Nash: The company was founded in 1983 to exploit a technology